Risks of using Ritalin without therapeutic indication

Detalhes bibliográficos
Autor(a) principal: Rocha , Paula Fernanda Lopes da
Data de Publicação: 2023
Outros Autores: Rocha , Yasmim Rodrigues, Leão , Natallia Moreira Lopes
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/41110
Resumo: Introduction: The consumption of the psychostimulant Methylphenidate (Ritalin®), indicated as a treatment option for Attention Deficit Hyperactivity Disorder (ADHD), is a current public health challenge in many parts of the world. The consumption of this medicine gradually increases, as its non-therapeutic use grows among students who aim to enhance their studies. Administering it without professional guidance and without medical prescriptions. Objective: The purpose of this study was to describe the health risks of using Ritalin® without therapeutic indication. Proposed Methodology: A descriptive and exploratory study was carried out based on an integrative literature review, conducting research and collecting scientific data organized through the investigation of articles associated with the object of study. A table was prepared with the purpose of objectively presenting the main information collected. Results: The results obtained were that until 2009 there were no published studies on the “non-medical” use of Ritalin® in Brazil. However, this subject has currently been widely discussed in the field of medicine due to the ethical and moral obstacles and the risks to the health of users. Therefore, it is believed that the group of medical students is more likely to use this medication to “boost the brain”. Final Considerations: The data show that there is a high prevalence of methylphenidate use, mainly by medical students, both prescribed and non-prescribed, mainly aiming at academic performance, agreeing with the literature regarding the possibility of a relationship between the course and the use of this psychostimulant.
id UNIFEI_35aa1fe99ff7adcc0da0c39d21685cbf
oai_identifier_str oai:ojs.pkp.sfu.ca:article/41110
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Risks of using Ritalin without therapeutic indication Riesgos de usar Ritalin sin indicación terapéutica Riscos do uso da Ritalina sem indicação terapêutica Ritalina®MetilfenidatoUso RacionalOff labelAssistência Farmacêutica.Ritalin®MetilfenidatoUso RacionalOff labelAtención Farmacéutica.Ritalin®MethylphenidateRational UseOff labelPharmaceutical Care.Introduction: The consumption of the psychostimulant Methylphenidate (Ritalin®), indicated as a treatment option for Attention Deficit Hyperactivity Disorder (ADHD), is a current public health challenge in many parts of the world. The consumption of this medicine gradually increases, as its non-therapeutic use grows among students who aim to enhance their studies. Administering it without professional guidance and without medical prescriptions. Objective: The purpose of this study was to describe the health risks of using Ritalin® without therapeutic indication. Proposed Methodology: A descriptive and exploratory study was carried out based on an integrative literature review, conducting research and collecting scientific data organized through the investigation of articles associated with the object of study. A table was prepared with the purpose of objectively presenting the main information collected. Results: The results obtained were that until 2009 there were no published studies on the “non-medical” use of Ritalin® in Brazil. However, this subject has currently been widely discussed in the field of medicine due to the ethical and moral obstacles and the risks to the health of users. Therefore, it is believed that the group of medical students is more likely to use this medication to “boost the brain”. Final Considerations: The data show that there is a high prevalence of methylphenidate use, mainly by medical students, both prescribed and non-prescribed, mainly aiming at academic performance, agreeing with the literature regarding the possibility of a relationship between the course and the use of this psychostimulant.Introducción: El consumo del psicoestimulante Metilfenidato (Ritalin®), indicado como opción de tratamiento para el Trastorno por Déficit de Atención con Hiperactividad (TDAH), es un desafío actual de salud pública en muchas partes del mundo. El consumo de este medicamento aumenta paulatinamente, a medida que crece su uso no terapéutico entre los estudiantes que pretenden perfeccionar sus estudios. Administrarlo sin orientación profesional y sin prescripción médica. Objetivo: El propósito de este estudio fue describir los riesgos para la salud del uso de Ritalin® sin indicación terapéutica. Metodología Propuesta: Se realizó un estudio descriptivo y exploratorio a partir de una revisión integrativa de la literatura, realizando una investigación y recolectando datos científicos organizados a través de la investigación de artículos asociados al objeto de estudio. Se elaboró ​​un cuadro con el propósito de presentar de manera objetiva la principal información recolectada. Resultados: Los resultados obtenidos fueron que hasta 2009 no había estudios publicados sobre el uso “no médico” de Ritalin® en Brasil. Sin embargo, en la actualidad este tema ha sido ampliamente discutido en el campo de la medicina debido a los obstáculos éticos, morales y los riesgos para la salud de los usuarios. Por lo tanto, se cree que el grupo de estudiantes de medicina es más propenso a usar este medicamento para “potenciar el cerebro”. Consideraciones Finales: Los datos muestran que existe una alta prevalencia de uso de metilfenidato, principalmente por estudiantes de medicina, tanto prescritos como no prescritos, con el objetivo principal de rendimiento académico, coincidiendo con la literatura en cuanto a la posibilidad de una relación entre el curso y el uso de este psicoestimulante.Introdução: O consumo do psicoestimulante Metilfenidato (Ritalina®), indicado como opção de tratamento do Transtorno do Déficit de Atenção e Hiperatividade (TDAH), é um desafio atual de saúde pública em várias partes do mundo. O consumo deste medicamento aumenta gradativamente, pois seu uso não terapêutico cresce entre estudantes que visam potencializar seus estudos. Fazendo a administração do mesmo sem orientação profissional e sem receitas médicas. Objetivo: O objetivo deste foi de descrever os riscos do uso da Ritalina® sem indicação terapêutica pode causar à saúde. Metodologia Proposta: Foi realizado um estudo descritivo e exploratório embasado em revisão de literatura integrativa, realizando pesquisa e recolhimento de dados científicos organizados por meio de apuração de artigos associados com o objeto do estudo. Elaborou-se um quadro com o propósito de apresentar de forma objetiva as principais informações coletadas. Resultados: Os resultados obtidos foram que até 2009 não existiam estudos publicados sobre o uso “não médico” da Ritalina® no Brasil. No entanto, atualmente esse assunto tem sido amplamente discutido no campo da medicina por conta dos entraves éticos, morais e dos riscos para a saúde dos usuários. Por conseguinte, acredita-se que o grupo de estudantes de medicina esteja mais propenso ao uso dessa medicação para “turbinar o cérebro”. Considerações Finais: Os dados mostram que há alta prevalência de uso de metilfenidato, principalmente por estudantes de medicina, tanto de forma prescrita, quanto não prescrita, principalmente objetivando desempenho acadêmico, concordando com a literatura quanto a possibilidade de relação entre o curso e o uso desse psicoestimulante.Research, Society and Development2023-04-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/4111010.33448/rsd-v12i4.41110Research, Society and Development; Vol. 12 No. 4; e17112441110Research, Society and Development; Vol. 12 Núm. 4; e17112441110Research, Society and Development; v. 12 n. 4; e171124411102525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/41110/33493Copyright (c) 2023 Paula Fernanda Lopes da Rocha ; Yasmim Rodrigues Rocha ; Natallia Moreira Lopes Leão https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRocha , Paula Fernanda Lopes da Rocha , Yasmim Rodrigues Leão , Natallia Moreira Lopes 2023-04-21T18:13:32Zoai:ojs.pkp.sfu.ca:article/41110Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2023-04-21T18:13:32Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Risks of using Ritalin without therapeutic indication
Riesgos de usar Ritalin sin indicación terapéutica
Riscos do uso da Ritalina sem indicação terapêutica
title Risks of using Ritalin without therapeutic indication
spellingShingle Risks of using Ritalin without therapeutic indication
Rocha , Paula Fernanda Lopes da
Ritalina®
Metilfenidato
Uso Racional
Off label
Assistência Farmacêutica.
Ritalin®
Metilfenidato
Uso Racional
Off label
Atención Farmacéutica.
Ritalin®
Methylphenidate
Rational Use
Off label
Pharmaceutical Care.
title_short Risks of using Ritalin without therapeutic indication
title_full Risks of using Ritalin without therapeutic indication
title_fullStr Risks of using Ritalin without therapeutic indication
title_full_unstemmed Risks of using Ritalin without therapeutic indication
title_sort Risks of using Ritalin without therapeutic indication
author Rocha , Paula Fernanda Lopes da
author_facet Rocha , Paula Fernanda Lopes da
Rocha , Yasmim Rodrigues
Leão , Natallia Moreira Lopes
author_role author
author2 Rocha , Yasmim Rodrigues
Leão , Natallia Moreira Lopes
author2_role author
author
dc.contributor.author.fl_str_mv Rocha , Paula Fernanda Lopes da
Rocha , Yasmim Rodrigues
Leão , Natallia Moreira Lopes
dc.subject.por.fl_str_mv Ritalina®
Metilfenidato
Uso Racional
Off label
Assistência Farmacêutica.
Ritalin®
Metilfenidato
Uso Racional
Off label
Atención Farmacéutica.
Ritalin®
Methylphenidate
Rational Use
Off label
Pharmaceutical Care.
topic Ritalina®
Metilfenidato
Uso Racional
Off label
Assistência Farmacêutica.
Ritalin®
Metilfenidato
Uso Racional
Off label
Atención Farmacéutica.
Ritalin®
Methylphenidate
Rational Use
Off label
Pharmaceutical Care.
description Introduction: The consumption of the psychostimulant Methylphenidate (Ritalin®), indicated as a treatment option for Attention Deficit Hyperactivity Disorder (ADHD), is a current public health challenge in many parts of the world. The consumption of this medicine gradually increases, as its non-therapeutic use grows among students who aim to enhance their studies. Administering it without professional guidance and without medical prescriptions. Objective: The purpose of this study was to describe the health risks of using Ritalin® without therapeutic indication. Proposed Methodology: A descriptive and exploratory study was carried out based on an integrative literature review, conducting research and collecting scientific data organized through the investigation of articles associated with the object of study. A table was prepared with the purpose of objectively presenting the main information collected. Results: The results obtained were that until 2009 there were no published studies on the “non-medical” use of Ritalin® in Brazil. However, this subject has currently been widely discussed in the field of medicine due to the ethical and moral obstacles and the risks to the health of users. Therefore, it is believed that the group of medical students is more likely to use this medication to “boost the brain”. Final Considerations: The data show that there is a high prevalence of methylphenidate use, mainly by medical students, both prescribed and non-prescribed, mainly aiming at academic performance, agreeing with the literature regarding the possibility of a relationship between the course and the use of this psychostimulant.
publishDate 2023
dc.date.none.fl_str_mv 2023-04-08
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/41110
10.33448/rsd-v12i4.41110
url https://rsdjournal.org/index.php/rsd/article/view/41110
identifier_str_mv 10.33448/rsd-v12i4.41110
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/41110/33493
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 12 No. 4; e17112441110
Research, Society and Development; Vol. 12 Núm. 4; e17112441110
Research, Society and Development; v. 12 n. 4; e17112441110
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052622128021504